首页> 外国专利> STATEMENT OF THE MEDICINAL PRODUCTS AND ROUTE(S) OF ADMINISTRATION

STATEMENT OF THE MEDICINAL PRODUCTS AND ROUTE(S) OF ADMINISTRATION

机译:医药产品说明书和行政路线

摘要

Pharmaceutical forms containing single variable areas with good solubility and stability under different storage conditions are provided,transport and voltage conditions. Pharmaceutical forms are useful as pharmaceutical forms. The pharmaceutical form consists of an aqueous medium with pH 5.5 to 8.0, a regulator selected from the group consisting of histidine with pH 6.0-6.5, hepes with pH 7.0-8.0, MES with pH 6.0, electric with pH 6.0-6.5 and acetic with pH 5,5-6.0, one emitter,and/or a surfactant selected from Tween 80, Tween 20 and polyoximer. The pharmaceutical form is further characterised by a concentration of 150 mM inorganic salt or lower. The invention further concerns containers and pharmaceuticals onlyAuthorisations consisting of such pharmaceutical forms and methods for the manufacture and condoms and therapeutic uses of pharmaceutical forms and units the invention.
机译:提供包含在不同储存条件,运输和电压条件下具有良好溶解性和稳定性的单一可变区域的药物形式。药物形式可用作药物形式。药物形式包括pH值为5.5至8.0的水性介质,调节剂,其选自pH值为6.0-6.5的组氨酸,pH 7.0-8.0的hepes,pH 6.0的MES,pH 6.0-6.5的电介质和乙酸的pH 5,5-6.0,一种发射剂和/或选自Tween 80,Tween 20和聚环氧乙烷的表面活性剂。药物形式的进一步特征在于浓度为150mM或更低。本发明进一步涉及仅由容器和药品组成的授权,该授权由这种药品形式和制造方法以及避孕套和药物用途以及本发明的药品形式和单位组成。

著录项

  • 公开/公告号CY1121411T1

    专利类型

  • 公开/公告日2020-05-29

    原文格式PDF

  • 申请/专利权人 ABLYNX N.V.;

    申请/专利号CY20191100137T

  • 申请日2019-01-31

  • 分类号A61K39/395;A61K9;A61K47/02;A61K47/14;A61K47/26;

  • 国家 CY

  • 入库时间 2022-08-21 11:17:56

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号